Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Reiter, Robert E
NCT01990196: Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer	Active, not recruiting	2	45	US	degarelix, Firmagon, FE200486, enzalutamide, Xtandi, MDV3100, trametinib, Mekinist, dasatinib, Sprycel, BMS-354825	Jonsson Comprehensive Cancer Center, Medivation, Inc., GlaxoSmithKline, Prostate Cancer Foundation, Astellas Pharma Inc, Novartis	Prostate Cancer	09/25	09/26
NCT03943368: Using Virtual Reality (VR) Models for Robotic Prostatectomy	Completed	N/A	92	US	Ceevra Reveal	Ceevra, Inc.	Prostate Cancer	09/23	09/23